SCIENCE@home

The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders

G. Cocks,S. Curran,Priya Gami,D. Uwanogho,A. Jeffries,A. Kathuria,W. Lucchesi,Victoria Wood,Rosemary Dixon,C. Ogilvie,T. Steckler,J. Price

Published 2013 in Psychopharmacology

ABSTRACT

Until now, models of psychiatric diseases have typically been animal models. Whether they were to be used to further understand the pathophysiology of the disorder, or as drug discovery tools, animal models have been the choice of preference in mimicking psychiatric disorders in an experimental setting. While there have been cellular models, they have generally been lacking in validity. This situation is changing with the advent of patient-specific induced pluripotent stem cells (iPSCs). In this article, we give a methodological evaluation of the current state of the iPS technology with reference to our own work in generating patient-specific iPSCs for the study of autistic spectrum disorder (ASD). In addition, we will give a broader perspective on the validity of this technology and to what extent it can be expected to complement animal models of ASD in the coming years.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-83 of 83 references · Page 1 of 1

CITED BY

Showing 1-51 of 51 citing papers · Page 1 of 1